Bukwang Pharm (003000) — Long-term Investment Intensity
Bukwang Pharm (003000) has a Long-term Investment Intensity of 13.6% as of December 2019. Long-term investments of ₩53.00 Billion represent 13.6% of total assets of ₩388.53 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 003000 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Bukwang Pharm Long-term Investment Intensity (2013–2019)
This chart shows how Bukwang Pharm's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 13.6%, reflecting long-term investments of ₩53.00 Billion against total assets of ₩388.53 Billion KRW. Explore debt repayment capacity of Bukwang Pharm to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Bukwang Pharm (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Bukwang Pharm from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Bukwang Pharm market capitalisation.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 13.6% | ₩53.00 Billion | ₩388.53 Billion | ▼ -9.5 pp |
| 2018 | 23.2% | ₩114.33 Billion | ₩493.62 Billion | ▲ +7.9 pp |
| 2017 | 15.2% | ₩36.02 Billion | ₩236.23 Billion | ▲ +3.2 pp |
| 2016 | 12.1% | ₩28.64 Billion | ₩237.63 Billion | ▲ +1.4 pp |
| 2015 | 10.6% | ₩27.00 Billion | ₩253.66 Billion | ▲ +6.6 pp |
| 2014 | 4.1% | ₩9.63 Billion | ₩236.82 Billion | ▲ +0.3 pp |
| 2013 | 3.8% | ₩8.62 Billion | ₩228.21 Billion | — |